PLEKHA5 anticorps (N-Term)

N° du produit ABIN7468751

Cet anticorps anti-PLEKHA5 est un anticorps Lapin Polyclonal détectant PLEKHA5 dans WB et IHC (p). Adapté pour Humain.

Aperçu rapide pour PLEKHA5 anticorps (N-Term) (ABIN7468751)

Antigène: PLEKHA5 (Pleckstrin Homology Domain Containing, Family A Member 5 (PLEKHA5))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp PLEKHA5 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Détail du produit anti-PLEKHA5 anticorps

Épitope: N-Term

Réactivité croisée: Humain

Purification: Purified by antigen-affinity chromatography.

Immunogène: Recombinant protein encompassing a sequence within the N-terminus region of human PEPP2. The exact sequence is proprietary.

Isotype: IgG

Information d'application

Indications d'application: WB: 1:500-1:3000. IHC-P: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.

Commentaires:

Positive Control: Jurkat

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1XPBS ( pH 7), 1 % BSA, 20 % Glycerol, 0.01 % Thimerosal

Agent conservateur: Thimerosal (Merthiolate)

Précaution d'utilisation: This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.

Détails sur PLEKHA5

Antigène: PLEKHA5 (Pleckstrin Homology Domain Containing, Family A Member 5 (PLEKHA5))

Autre désignation: pleckstrin homology domain containing A5

Sujet: Pleckstrin homology domain containing A5 , PEPP-2 , PEPP2

Poids moléculaire: 127 kDa

ID gène: 54477

UniProt: Q9HAU0

Pathways: SARS-CoV-2 Protein Interactome, Phosphorylation & l'infection par le SRAS-CoV-2